Food ingredient review at FDA: recent data and initiatives to improve the process.
作者信息
Rulis A M, Tarantino L M
机构信息
U.S. Food & Drug Administration, 200 C Street, SW (HFS-200), Washington, DC, 20204, USA.
出版信息
Regul Toxicol Pharmacol. 1996 Dec;24(3):224-31. doi: 10.1006/rtph.1996.0132.
PMID:8975749
Abstract
摘要
相似文献
1
Food ingredient review at FDA: recent data and initiatives to improve the process.美国食品药品监督管理局的食品成分审查：近期数据及改进审查流程的举措
Regul Toxicol Pharmacol. 1996 Dec;24(3):224-31. doi: 10.1006/rtph.1996.0132.
2
Generally recognized as safe (GRAS): history and description.一般公认为安全（GRAS）：历史与描述
Toxicol Lett. 2004 Apr 15;150(1):3-18. doi: 10.1016/j.toxlet.2003.07.004.
3
Food contact substances and the need for food safety reform.食品接触物质与食品安全改革的必要性。
Regul Toxicol Pharmacol. 1996 Dec;24(3):236-9. doi: 10.1006/rtph.1996.0134.
4
From aspartame to Xenical. A look at the FDA review process.从阿斯巴甜到赛尼可。看一看美国食品药品监督管理局的审评过程。
J Am Diet Assoc. 1999 Jul;99(7):797-8. doi: 10.1016/S0002-8223(99)00189-3.
5
Origins and causes of the problem: the regulatory context.问题的起源与成因：监管背景
Regul Toxicol Pharmacol. 1996 Dec;24(3):214-7. doi: 10.1006/rtph.1996.0130.
6
Food industry initiatives to improve the FDA's food ingredient review processes.食品行业为改进美国食品药品监督管理局（FDA）食品成分审查流程所采取的举措。
Food Drug Law J. 1996;51(3):413-21.
7
Optimizing the review process of food additive and GRAS petitions. Overview of the workshop.优化食品添加剂和一般认为安全（GRAS）申请的审核流程。研讨会概述。
Regul Toxicol Pharmacol. 1996 Dec;24(3):242-5. doi: 10.1006/rtph.1996.0136.
8
Can FDA seek restitution or disgorgement?美国食品药品监督管理局（FDA）能否寻求恢复原状或吐出非法所得？
Food Drug Law J. 2003;58(2):129-47.
9
Macronutrient substitutes: are regulatory options possible?常量营养素替代物：是否存在可行的监管选项？
Regul Toxicol Pharmacol. 1996 Feb;23(1 Pt 2):S38-41. doi: 10.1006/rtph.1996.0025.
Zotero 插件